Biophage Pharma Inc.
Biophage Inc. is a privately held Montreal based
biopharmaceutical company founded in 1995 that discovers and
develops proprietary therapeutic products for the treatment of
inflammation in humans and bacterial infections in livestock and
humans. Biophage technology platforms are based on the unique
properties of phages and antibodies
Biophage operates two divisions: (1) The R & D division and (2)
The Contract Research Organization (CRO) division.
Biophage R & D division develops the Companys compounds with
the objective of taking them to the market place or licensing
them to Pharmaceutical companies once clear proof of concept has
been established.
Biophage CRO division supports biotech and pharma companies in
their early drug development by providing In vitro and In vivo
development services in the fields of immunology, infectiology
and oncology. Biophage provides assistance and support in
developing customized screens and experimental models tailored
to meet its clients specialized analytical requirements. The
identity of clients and test results are handled under strict
confidentiality. Our technical staff has extensive training and
experience in:
- Drug discovery and early stage drug development;
- Molecular Biology services including mRNA protection assay, RT-
PCR, 2-Hybrid system,
- Custom antibody production, purification and antigenic
prediction;
- Immunoassay development (Elisa, RIA, etc);
- Immunology and Immunotoxicology including 3-color Flow
Cytometry, Cytokines, Effector cells evaluation
- Cell culture testing (mycoplasma and sterility testing);
- Phage display technologies and phage therapeutics
- Immune Modulators and Anti-infectives activity testing
- Development of mammalian and bacterial vectors
Efficacy tests including: (i) immunology and immunotoxicology;
(ii) in vitro and in vivo anti-tumor profiling using our panel
of over 130 human and rodent cell lines; (iii) complete and
integrated services of necropsy and histopathology; (iv)
microbiological testing (bacteria, virus and fungi); and (v)
pilot toxicological studies in rodents.
Biophage Inc. senior management team has over 100 years of
combined experience in business and technology development in
health care and biotechnology industries. Biophage is led by
Rosemonde Mandeville, M.D., Ph.D., (President, CEO & CSO).
Company Details
Year Established:
1995
Total Sales ($CDN):
$100,000 - $200,000
Number of Employees:
21
Company Information
Rosemonde Mandeville
Title:
Chief Executive Officer
Area of Responsibility:
Management Executive
Telephone:
(514) 496-1488
Fax:
(514) 496-1521
Email:
Click Here
Elie Farah
Title:
Chief Operating Officer
Area of Responsibility:
Domestic Sales & Marketing
Telephone:
(514) 496-1488
Fax:
(514) 496-1521
Email:
Click Here
Services
Custom Research Services
Biotechnology